Category: News

Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its personalised cancer therapy drugs, PTX-100. The results of the Phase 1b study means that PTX-100 can now move to the next level dose with two out of three patients from the first cohort showing stable or improved disease.

Titomic (AX: TTT) is an additive manufacturing company that showcases Australia’s potential in advanced, green technology. Titomic specialises in 3D printing high-performance metals for the same cost of traditional manufacturing. As well as producing metals, Titomic conducts its own Research & Development.

As gold runs at all time highs and Victoria ushers in a new gold rush, North Stawell Minerals (ASX: NSM) has launched its initial public offering. Talk about perfect timing!The IPO will raise AUD $20 million through 40 million shares at $0.50 a piece.

Optima Nutricosmetics is an Australian nutricosmetics company that offers daily collagen-based supplements that promote skin and gut health.

Every year 45,000 of the most respected professionals in oncology gather at the American Society of Clinical Oncology (ASCO) annual meeting. This year the meeting was abuzz with clinical research news about CAR T-cell therapy, including Johnson and Johnson reporting a 100% recovery rate from its ongoing multiple myeloma (Blood Cancer) trial. The headline grabbing efficacy number is that there are now 25 complete responders in the 29-strong Cartitude-1 dataset. Earlier data cut had reported 22 complete remissions.

Ever wonder how gold companies like Anglo Gold Ashanti, Gold Fields, Newcrest, Newmont or Kinross report their mineral inventory to the stock market? Many household names in the resources sector use or are implementing K2Fly’s Software as a Service (SaaS).

At a time when the sale of electric vehicles are growing, one only needs to look at Tesla share prices to see where global car markets are headed and how key businesses stand to benefit greatly. One Australian company well positioned to take advantage of this growing market is Core Lithium (ASX: CXO), which represents a high quality lithium opportunity.

Last week Reach Markets was  joined for an online fireside chat by the founder and executive chairman of Thorney Investments, Alex Waislitz. In the session he discussed his view on the current market, how he approaches investing and the themes and trends he is currently focused on.

Last month, the best and brightest minds in oncology gathered (virtually) for the American Society of Clinical Oncology (ASCO) annual conference. The conference was ablaze with talk about the biggest breakthrough in cancer research since chemotherapy, CAR-T. One of the significant CAR-T talking points was Johnson & Johnson’s CAR-T (JNJ-4528) announcement in multiple myeloma. 

US-China tensions prompted gold to hit its highest ever price on Monday. Following the tit-for-tat consulate closures in Houston and Chengdu, gold reached $US1,940 per ounce, adding 2% to last week’s gains of 7%. 

COVID-19 is the biggest shock to the world since World War II. Could it trigger a permanent change to the way we do capitalism? In 2011, geopolitical expert Ian Bremmer foretold a potential power vacuum as China emerged, Russia got bolshy, social media took hold and the West started to lose relevance. 

Clinical stage oncology company Prescient Therapeutics (ASX: PTX) has announced that two of its assets will be used for a COVID-19 antiviral testing program in Melbourne, Victoria. PTX signed the research agreement with the Peter Doherty Institute for Infection and Immunology after coming out of a trading halt on Tuesday. They have also pledged $70,000 in funding.